Annual Drug Patent Expirations for EYSUVIS
Eysuvis is a drug marketed by Kala Pharms Inc and is included in one NDA. There are twelve patents protecting this drug.
This drug has seventy-four patent family members in twelve countries.
The generic ingredient in EYSUVIS is loteprednol etabonate. Additional details are available on the loteprednol etabonate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
